Zhi Guo

1.1k total citations
24 papers, 874 citations indexed

About

Zhi Guo is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Zhi Guo has authored 24 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Nephrology. Recurrent topics in Zhi Guo's work include Advanced Glycation End Products research (4 papers), Hair Growth and Disorders (2 papers) and Glioma Diagnosis and Treatment (2 papers). Zhi Guo is often cited by papers focused on Advanced Glycation End Products research (4 papers), Hair Growth and Disorders (2 papers) and Glioma Diagnosis and Treatment (2 papers). Zhi Guo collaborates with scholars based in China, South Korea and Japan. Zhi Guo's co-authors include Fan Fan Hou, Di Xie, Guo Bao Wang, Xun Zhang, Zhan Zhou, Min Liang, Jian Jiang, Min Liang, Qiu Gen Zhou and Xun Zhang and has published in prestigious journals such as Endocrinology, Journal of the American Society of Nephrology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Zhi Guo

22 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhi Guo China 12 195 182 175 158 144 24 874
Maki Murakoshi Japan 18 369 1.9× 118 0.6× 218 1.2× 135 0.9× 223 1.5× 55 905
Bryna S.M. Chow Australia 10 276 1.4× 177 1.0× 326 1.9× 177 1.1× 216 1.5× 12 1.0k
Steffi Kopprasch Germany 18 181 0.9× 97 0.5× 254 1.5× 145 0.9× 233 1.6× 56 1.1k
Mitsuo Tanimoto Japan 20 396 2.0× 198 1.1× 222 1.3× 180 1.1× 251 1.7× 45 1.1k
Ryohei Kaseda Japan 17 472 2.4× 150 0.8× 275 1.6× 111 0.7× 252 1.8× 39 1.1k
Jianmin Ran China 14 152 0.8× 175 1.0× 182 1.0× 148 0.9× 244 1.7× 41 795
Xiangdong Yang China 18 251 1.3× 76 0.4× 297 1.7× 115 0.7× 61 0.4× 57 975
Jin Young Jeong South Korea 14 185 0.9× 95 0.5× 225 1.3× 95 0.6× 135 0.9× 29 778
Masatoshi Mune Japan 18 386 2.0× 81 0.4× 183 1.0× 133 0.8× 134 0.9× 61 1.1k
Josefa Pete Australia 7 186 1.0× 79 0.4× 329 1.9× 118 0.7× 197 1.4× 9 891

Countries citing papers authored by Zhi Guo

Since Specialization
Citations

This map shows the geographic impact of Zhi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Guo more than expected).

Fields of papers citing papers by Zhi Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Guo. The network helps show where Zhi Guo may publish in the future.

Co-authorship network of co-authors of Zhi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Guo. A scholar is included among the top collaborators of Zhi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Guo. Zhi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ji, Mei-Mei Zheng, Wu Lv, et al.. (2025). Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer. Nature Reviews Clinical Oncology. 22(8). 546–565. 3 indexed citations
2.
Zhang, Xiuli, Ying Cheng, Yao Lu, et al.. (2025). DAPK1 acts as a positive regulator of hypertension via induction of vasoconstriction. Clinical Science. 139(12). 667–681. 1 indexed citations
3.
Wang, Ziyan, Zhi Guo, Wu Lv, et al.. (2024). Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions. Cancers. 16(2). 304–304.
4.
Wang, Yinghui, Jing Xie, Zhi Guo, et al.. (2024). The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway. Cell Biology and Toxicology. 40(1). 45–45.
5.
Guo, Zhi, Meizhu Wu, Aling Shen, et al.. (2023). Gastrodin attenuates angiotensin II-induced vascular contraction and MLCK/p-MLC 2 pathway activation. Pharmaceutical Biology. 61(1). 858–867. 12 indexed citations
6.
Qu, Qian, Ye He, Zhi Guo, et al.. (2022). Efficacy of Platelet-Rich Plasma plus Basic Fibroblast Growth Factor on the Treatment of Androgenic Alopecia. Plastic & Reconstructive Surgery. 151(4). 630e–640e. 9 indexed citations
7.
Niu, Xinli, Yinghui Wang, Zhi Guo, et al.. (2022). Targeting MALT1 Suppresses the Malignant Progression of Colorectal Cancer via miR-375/miR-365a-3p/NF-κB Axis. Frontiers in Cell and Developmental Biology. 10. 845048–845048. 6 indexed citations
8.
Dai, Yu, Yinghui Wang, Xinli Niu, et al.. (2021). Autophagy attenuates particulate matter 2.5-induced damage in HaCaT cells. Annals of Translational Medicine. 9(12). 978–978. 8 indexed citations
9.
Chen, Jian, Zhexiang Fan, Yilong Guo, et al.. (2021). Emerging Role of Dermal White Adipose Tissue in Modulating Hair Follicle Development During Aging. Frontiers in Cell and Developmental Biology. 9. 728188–728188. 15 indexed citations
10.
Zhou, Jing, Hao Guo, Likun Liu, et al.. (2021). Construction of co‐expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma. Journal of Cellular and Molecular Medicine. 25(3). 1633–1644. 34 indexed citations
11.
Zhou, Jing, Yaocheng Li, Fupeng Zhang, et al.. (2021). Oridonin inhibits tumor angiogenesis and induces vessel normalization in experimental colon cancer. Journal of Cancer. 12(11). 3257–3264. 27 indexed citations
12.
Liu, Yang, Fang Liu, Qian Qu, et al.. (2020). Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of female pattern hair loss. Lasers in Medical Science. 36(5). 1085–1093. 16 indexed citations
13.
Guo, Zhi, Jinxiang Wu, Jiping Zhao, et al.. (2014). IL-33 promotes airway remodeling and is a marker of asthma disease severity. Journal of Asthma. 51(8). 863–869. 85 indexed citations
14.
Guo, Zhi, Fan Fan Hou, Di Xie, et al.. (2009). Picrorhiza scrophulariiflora improves accelerated atherosclerosis through inhibition of redox-sensitive inflammation. International Journal of Cardiology. 136(3). 315–324. 8 indexed citations
15.
He, Li, Min Liang, Fan Fan Hou, et al.. (2008). Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action. Journal of Endocrinology. 200(3). 347–355. 37 indexed citations
16.
Zhou, Qiu Gen, Fan Fan Hou, Zhi Guo, et al.. (2008). 1,25‐Dihydroxyvitamin D improved the free fatty‐acid‐induced insulin resistance in cultured C2C12 cells. Diabetes/Metabolism Research and Reviews. 24(6). 459–464. 118 indexed citations
17.
Guo, Zhi, et al.. (2008). Uncommon Primary Adrenal T-cell Lymphoma. The Endocrinologist. 18(2). 77–80. 1 indexed citations
18.
Shi, Xiao, Fan Fan Hou, Guo Bao Wang, et al.. (2008). Advanced Oxidation Protein Products Promote Inflammation in Diabetic Kidney through Activation of Renal Nicotinamide Adenine Dinucleotide Phosphate Oxidase. Endocrinology. 149(4). 1829–1839. 110 indexed citations
19.
Hou, Fan Fan, et al.. (2007). Advanced Glycation End Products Upregulate C‐reactive Protein Synthesis by Human Hepatocytes Through Stimulation of Monocyte IL‐6 and IL‐1β Production. Scandinavian Journal of Immunology. 66(5). 555–562. 28 indexed citations
20.
Hou, Fan Fan, Di Xie, Xun Zhang, et al.. (2007). Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study. Journal of the American Society of Nephrology. 18(6). 1889–1898. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026